Skip to main content
Clinical Trials/NCT06882291
NCT06882291CompletedNot Applicable

Intermittent Fasting Diet Versus Resistive Exercise Program on Insulin Resistance in Obese Women With P.C.O.S

Cairo University1 site in 1 country72 target enrollmentStarted: March 20, 2025Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
72
Locations
1
Primary Endpoint
HOM-IR calculation

Study Overview

Brief Summary

This study will be carried out in an attempt to know which is more effective, Intermittent fasting diet or resistive exercise program on insulin resistance in obese woman with polycystic ovarian syndrome.

Detailed Description

Polycystic ovarian syndrome (PCOS) significantly impacts women, since the broad spectrum of clinical manifestations associated with it are significant and include reproductive dysfunction, menstrual irregularities, and an increased risk of infertility. However, the consequences of PCOS go beyond the reproductive axis, with psychological and social impairments, including stress, depression, anxiety and sexual dissatisfaction. There is also a high prevalence of dyslipidemia, hyperinsulinemia, obesity, hypertension, and glucose intolerance which are risk factors that predispose women to cardiovascular disease (CVD) and diabetes mellitus type 2 (DM2).

Improving Insulin resistance and excess adiposity are therefore key targets in PCOS management. International Evidence Based Guideline for the Assessment and Management of PCOS , highlights lifestyle intervention as the primary early management strategy. Lifestyle interventions are traditionally defined as those designed to improve dietary intake or physical activity through appropriate behavioural support. Time restricted eating (TRF), where patients are asked to consume all energy within a restricted daily time period, appears to offer more sustainable weight loss and cardiometabolic changes and may be more acceptable as a permanent lifestyle change.

Eight hour TRF may have beneficial effects on improving menstruation, hyperandrogenemia and reducing weight especially body fat, decreasing insulin resistance and chronic inflammation in women with anovulatory PCOS. TRF may be suitable for PCOS women with appropriate counseling and patient management.

The progressive resistance training (PRT) improved hyperandrogenism and the menstrual cycle as well as the functional capacity with increased muscle strength and resulted in changes in body composition with increased lean muscle mass and decreased central obesity without a reduced total weight. There were also improvements in quality of life and sexual function as complementary benefits.

So, This study will be carried out in an attempt to know Which is more effective, Intermittent fasting diet or resistive exercise program on insulin resistance in obese woman with polycystic ovarian syndrome.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
25 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Seventy two obese women diagnosed with Polycystic ovarian syndrome by the gynecologist (based on the Rotterdam diagnostic criteria)
  • •Their age will range from 25 to 40 years old.
  • •Overweight or obese (BMI >25 kg/m2 and < 30 kg/m2).

Exclusion Criteria

  • •The presence of diseases (such as congenital adrenal hyperplasia, Cushing syndrome, androgen secreting tumors, hyperprolactinemia, diabetes, thyroid diseases, Severe serious cardiovascular, gastrointestinal, kidney and liver diseases. premature ovarian failure, hypothalamic/pituitary disease
  • •Hormonal contraceptive use.
  • •Participants who did not complete the study were excluded from the analysis.
  • •Use of medication therapy that impacts carbohydrate or lipid metabolism (oral contraceptive pills, insulin sensitizers, anti epileptics, anti psychotics, statins, and fish oil) in the recent 6 months;
  • •Body weight fluctuations for more than 5% in the past 3 months; in preparation for pregnancy.
  • •Perimenopausal; night shift workers; fasting for more than 16 h per day; hypotension
  • •Alcohol intake for more than 100 g per week; smoking within the past 3 months
  • •Engaging in high intensity exercise.

Arms & Interventions

Intermittent fasting diet + medical treatment

Experimental

This group will consist of 24 obese PCOS women who will receive a program of Intermittent fasting diet for eight weeks and a medical treatment.

Intervention: Intermittent fasting diet (Other)

Intermittent fasting diet + medical treatment

Experimental

This group will consist of 24 obese PCOS women who will receive a program of Intermittent fasting diet for eight weeks and a medical treatment.

Intervention: Medical treatment (Drug)

Resistive exercise program + medical treatment

Experimental

This group will consist of 24 obese PCOS women who will receive a resistive exercise program for 30 minutes 5 times/week for eight weeks and a medical treatment.

Intervention: Resistive exercise program (Other)

Resistive exercise program + medical treatment

Experimental

This group will consist of 24 obese PCOS women who will receive a resistive exercise program for 30 minutes 5 times/week for eight weeks and a medical treatment.

Intervention: Medical treatment (Drug)

Medical treatment

Active Comparator

This group will consist of 24 obese PCOS women who will receive a medical treatment only.

Intervention: Medical treatment (Drug)

Outcomes

Primary Outcomes

HOM-IR calculation

Time Frame: 8 weeks

It is calculated from fasting glucose and fasting insulin. Different studies provide slightly different ranges for HOM-IR. But they all agree that the higher HOM-IR gets , the more insulin resistance are. Less than 1 : optimal insulin resistance. Above 1.9 : early insulin resistance. Above 2.9 : significant insulin resistance.

Secondary Outcomes

  • Weight measurement(8 weeks)
  • Waist circumference measurement(8 weeks)
  • Waist/ hip ratio assessment(8 weeks)
  • Body mass index (BMI) measurement(8 weeks)
  • Body fat mass (BFM) measurement(8 weeks)
  • Skeletal muscle mass (SMM) measurement(8 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Wesam Samy Elsayed Elmokadem

Principal Investigator

Cairo University

Study Sites (1)

Loading locations...

Similar Trials